Search Within

Hebert Alberto Vargas Alvarez

  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (35)
  2. Meeting Abstract (8)
  3. Correspondence (3)
  4. Review (1)
Groups
  1. Department of Medicine (47)
  2. Molecular Imaging and Therapy Service (47)
  3. Solid Tumor Oncology Division (47)
  4. Genitourinary Oncology Service (39)
  5. Surgery (24)
  6. Epidemiology and Biostatistics (22)

More Groups

People
  1. Howard Scher (20)
  2. Michael Morris (15)
  3. Hedvig Hricak (9)
  4. Andreas Wibmer (8)
  5. Bernard Bochner (8)
  6. Dean Bajorin (8)

More People

Years
  1. 2024 (1)
  2. 2023 (4)
  3. 2022 (3)
  4. 2021 (6)
  5. 2020 (6)
  6. 2019 (6)

More Years

Publications
  1. Journal of Clinical Oncology (8)
  2. Journal of Urology (5)
  3. Journal of Nuclear Medicine (4)
  4. JAMA Oncology (3)
  5. Urology (3)
  6. Cancer Imaging (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. Elsevier Science, Inc. (9)
  3. Society of Nuclear Medicine (4)
  4. American Association for Cancer Research (3)
  5. American Medical Association (3)
  6. Nature Publishing Group (3)

More Publishers

Results (47)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy
    Journal Article

    Walmsley, C. S.; Jonsson, P.; Cheng, M. L.; McBride, S.; Kaeser, C.; Vargas, H. A.; Laudone, V.; Taylor, B. S.; Kappagantula, R.; Baez, P.; more...
    npj Precision Oncology (2024)

    Fulltext@MSK | Save
  • Synoptic reporting for pretreatment CT examination in patients with advanced ovarian cancer: Impact on documentation of disease sites and physician satisfaction
    Journal Article

    Andrieu, P. C.; Nikolovski, I.; Juluru, K.; Sadowski, E.; Gangai, N.; Zheng, J.; Capanu, M.; Praiss, A. M.; Nougaret, S.; Shinagare, A. B.; more...
    American Journal of Roentgenology (2023)

    Fulltext@MSK | Save
  • Evaluating residual tumor after neoadjuvant chemotherapy for muscle-invasive urothelial bladder cancer: Diagnostic performance and outcomes using biparametric vs. multiparametric MRI
    Journal Article

    Woo, S.; Becker, A. S.; Das, J. P.; Ghafoor, S.; Arita, Y.; Benfante, N.; Gangai, N.; Teo, M. Y.; Goh, A. C.; Vargas, H. A.
    Cancer Imaging (2023)

    Fulltext@MSK | Save
  • Multicenter phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma
    Journal Article

    Coleman, J. A.; Yip, W.; Wong, N. C.; Sjoberg, D. D.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Cha, E. K.; Donahue, T. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Automated analysis of FDG-PET/CT imaging to monitor heterogeneous disease response in metastatic castration-resistant prostate cancer
    Meeting Abstract

    Barnett, E.; Woo, S.; Perk, T. G.; Munian-Govindan, R.; Lokre, O.; Gajar, R. N.; Erazo, T.; Carbone, E.; Morris, M. J.; Vargas, H. A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Associations of body fat distribution and cardiometabolic risk of testicular cancer survivors after cisplatin-based chemotherapy
    Journal Article

    Wibmer, A. G.; Dinh, P. C. Jr; Travis, L. B.; Chen, C.; Bromberg, M.; Zheng, J.; Capanu, M.; Sesso, H. D.; Feldman, D. R.; Vargas, H. A.
    JNCI Cancer Spectrum (2022)

    Fulltext@MSK | Save
  • Final results of a multicenter prospective phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy in patients with high-grade upper tract urothelial carcinoma
    Meeting Abstract

    Yip, W.; Coleman, J.; Wong, N. C.; Sjoberg, D. D.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Pietzak, E. J.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Correlation between imaging-based intermediate endpoints and overall survival in men with metastatic castration-resistant prostate cancer: Analysis of 28 randomized trials using the Prostate Cancer Clinical Trials Working Group (PCWG2) criteria in 16,511 patients
    Journal Article

    Woo, S.; Suh, C. H.; Wibmer, A. G.; Becker, A. S.; Teo, M. Y.; Gönen, M.; Hricak, H.; Scher, H. I.; Morris, M. J.; Vargas, H. A.
    Clinical Genitourinary Cancer (2022)

    Fulltext@MSK | Save
  • Effect of pretreatment central adiposity on the cardiometabolic risk of male germ cell tumor survivors after cisplatin-based chemotherapy
    Meeting Abstract

    Wibmer, A. G.; Feldman, D. R.; Chen, C.; Bromberg, M.; Dinh, P. C.; Zheng, J.; Capanu, M.; Travis, L. B.; Vargas, H. A.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Quantification of metastatic prostate cancer whole-body tumor burden with (18)F-FDG PET parameters and associations with overall survival after first-line abiraterone or enzalutamide: A single-center retrospective cohort study
    Journal Article

    Wibmer, A. G.; Morris, M. J.; Gonen, M.; Zheng, J.; Hricak, H.; Larson, S.; Scher, H. I.; Vargas, H. A.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save